Gelteq Limited (GELS)

Profile

Full Name

Gelteq Limited

Ticker Symbol

GELS

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Australia

IPO

Indexes

Not included

Website

http://www.gelteq.com

Employees

7

Key Details

Price

$0.87(-6.02%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.25(+1.44% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.87
GELS price is $0.87

30-Day Relative Volume

0.37
GELS 30-day relative volume is 0.37

Price Performance

Price Most recent change

-6.02%
GELS price was down -6.02% on Apr 16, 2025

Price YTD change

-62.33%
GELS price is down -62.33% since January 1st

Price 1-year change

-
GELS price 1-year change is unknown

Price 3-year change

-
GELS price 3-year change is unknown

Price Range

Price All-time high

$5.50
GELS price is currently -84.11% below its historical high of $5.50

Price 3-year low

$0.77
GELS price is currently +13.51% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.25M
GELS market capitalization is $8.25 million

Market cap 3-year change

-
GELS market capitalization 3-year change is unknown

Market cap All-time high

$45.21M
GELS market capitalization is currently -81.75% below its historical high of $45.21 million

Market cap sector rank

17.68%
GELS market capitalization is higher than 17.68% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
GELS shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
GELS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
GELS beta is 0.60

200-day SMA

$1.99
GELS price is currently -56.06% below its 200-day simple moving average

50-day SMA

$1.41
GELS price is currently -38.19% below its 50-day simple moving average

RSI

34.85
GELS 14-day relative strength index is 34.85

Volume

0.37
GELS 30-day relative volume is 0.37

ATR

$0.15
GELS average true range is $0.15

10-day Historical Volatility

110.38%
GELS 10-day historical volatility is 110.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
GELS annual revenue value is unknown

Revenue Analysts estimate

-
GELS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
GELS annual revenue 1-year change is unknown

Revenue Sector rank

-
GELS annual revenue is unknown

EPS

EPS

-$0.25
GELS annual earnings per share is -$0.25

EPS Analysts estimate

-
GELS annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+1.44%
GELS annual earnings per share is up +1.44% year-on-year

EPS Sector rank

76.28%
GELS annual earnings per share is higher than 76.28% of companies in Healthcare sector

Profit

Gross profit

$0.00
GELS annual gross profit is $0.00

Gross margin

-
GELS annual gross profit margin value is unknown

Operating profit

-$1.82M
GELS annual operating income is -$1.82 million

Operating margin

-
GELS annual operating profit margin value is unknown

Net income

-$2.32M
GELS annual net profit is -$2.32 million

Net margin

-
GELS annual net profit margin value is unknown

Expenses

Total expenses

$1.82M
GELS annual total expenses is $1.82 million

Operating expenses

$1.82M
GELS annual total operating expenses is $1.82 million

Cost of goods sold

-
GELS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$830.60K
GELS annual SGA is $830.60 thousand

Depreciation and amortization

-
GELS annual depreciation & amortization value is unknown

Interest expense

$383.60K
GELS annual interest expense is $383.60 thousand

Income tax

$0.00
GELS annual income tax is $0.00

EBIT & EBITDA

EBIT

-$1.94M
GELS annual earnings before interest & taxes is -$1.94 million

EBITDA

-$1.15M
GELS annual EBITDA is -$1.15 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.87M
GELS annual total assets is $13.87 million

Non current assets

$13.67M
GELS annual long term assets is $13.67 million

Current assets

$202.70K
GELS annual total current assets is $202.70 thousand

Cash and cash equivalents

$16.40K
GELS annual cash & cash equivalents is $16.40 thousand

Accounts receivable

$5500.00
GELS annual accounts receivable is $5500.00

Inventory

$0.00
GELS annual inventory is $0.00

Liabilities

Total liabilities

$3.77M
GELS annual total liabilities is $3.77 million

Long term liabilities

$1.19M
GELS annual total long term liabilities is $1.19 million

Current liabilities

$2.58M
GELS annual total current liabilities is $2.58 million

Accounts payable

$258.70K
GELS annual accounts payable is $258.70 thousand

Debt

Total debt

$2.57M
GELS annual total debt is $2.57 million

Total debt 1-year change

+55.96%
GELS annual total debt is up +55.96% year-on-year

Long term debt

$1.18M
GELS annual long term debt is $1.18 million

Short term debt

$1.39M
GELS annual short term debt is $1.39 million

Equity & Capital

Shareholders equity

$10.10M
GELS annual stockholders equity is $10.10 million

Book value

$10.10M
GELS annual book value is $10.10 million

Retained earnings

-$7.68M
GELS annual retained earnings is -$7.68 million

Working capital

-$2.38M
GELS annual working capital is -$2.38 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
GELS annual cash flow from operations value is unknown

Cash from operations 1-year change

-
GELS annual cash flow from operations 1-year change is unknown

Cash from investing

-$97.10K
GELS annual cash flow from investing activities is -$97.10 thousand

Cash from investing 1-year change

-90.02%
GELS annual cash flow from investing activities is down -90.02% year-on-year

Cash from financing

$553.30K
GELS annual cash flow from financing activities is $553.30 thousand

Cash from financing 1-year change

-59.5%
GELS annual cash flow from financing activities is down -59.5% year-on-year

CAPEX

CAPEX

-
GELS annual capital expenditures value is unknown

CAPEX 1-year change

-
GELS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-
GELS annual free cash flow value is unknown

Free cash flow 1-year change

-
GELS annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GELS annual gross profit margin value is unknown

Operating margin

-
GELS annual operating profit margin value is unknown

Net margin

-
GELS annual net profit margin value is unknown

ROA & ROE

ROA

-16.76%
GELS annual return on assets is -16.76%

ROE

-23.02%
GELS annual return on equity is -23.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GELS price to earnings ratio value is unknown

PE ratio Sector rank

-
GELS price to earnings ratio is unknown

PB Ratio

PB ratio

0.82
GELS price to book ratio is 0.82

PB ratio Sector rank

41.02%
GELS price to book ratio is higher than 41.02% of companies in Healthcare sector

PS Ratio

PS ratio

-
GELS price to sales ratio value is unknown

PS ratio Sector rank

-
GELS price to sales ratio is unknown

Enterprise value

Enterprise value

$10.80M
GELS enterprise value is $10.80 million

Enterprise value Sector rank

26.01%
GELS enterprise value is higher than 26.01% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-24.10
GELS EV/EBITDA is -24.10

EV/EBITDA Sector rank

5.22%
GELS EV/EBITDA is higher than 5.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.08
GELS annual current ratio is 0.08

Quick ratio

0.08
GELS annual quick ratio is 0.08

Leverage

Debt to equity

0.25
GELS annual debt to equity ratio is 0.25

Interest coverage ratio

-5.06
GELS annual interest coverage ratio is -5.06

Risk & Stability

Piotroski F-Score

-
GELS piotroski f-score value is unknown

Altman Z-Score

-
GELS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

KPRX logo
Kiora Pharmaceuticals (KPRX)
EVAX logo
Evaxion Biotech A/S (EVAX)
OSA logo
ProSomnus (OSA)
PRPO logo
Precipio (PRPO)
DHAI logo
DIH Holdings US Class A (DHAI)
AIMD logo
Ainos (AIMD)
APRE logo
Aprea Therapeutics (APRE)
Scienture Holdings (SCNX)
CARM logo
Carisma Therapeutics (CARM)
  • What is the ticker symbol for Gelteq Limited?
  • Does Gelteq Limited pay dividends?
  • What sector is Gelteq Limited in?
  • What industry is Gelteq Limited in?
  • What country is Gelteq Limited based in?
  • Is Gelteq Limited in the S&P 500?
  • Is Gelteq Limited in the NASDAQ 100?
  • Is Gelteq Limited in the Dow Jones?
  • When does Gelteq Limited report earnings?

What is the ticker symbol for Gelteq Limited?

The ticker symbol for Gelteq Limited is NASDAQ:GELS

Does Gelteq Limited pay dividends?

No, Gelteq Limited does not pay dividends

What sector is Gelteq Limited in?

Gelteq Limited is in the Healthcare sector

What industry is Gelteq Limited in?

Gelteq Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Gelteq Limited based in?

Gelteq Limited is headquartered in Australia

Is Gelteq Limited in the S&P 500?

No, Gelteq Limited is not included in the S&P 500 index

Is Gelteq Limited in the NASDAQ 100?

No, Gelteq Limited is not included in the NASDAQ 100 index

Is Gelteq Limited in the Dow Jones?

No, Gelteq Limited is not included in the Dow Jones index

When does Gelteq Limited report earnings?

The date for Gelteq Limited's next earnings report has not been announced yet
On this page